Hypersensitivity to trastuzumab, murine proteins, hyaluronidase or to any of the other excipients listed in Description.
Severe dyspnoea at rest due to complications of advanced malignancy or requiring supplementary oxygen therapy.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.